Intellia Therapeutics Inc Headquarters

Looking for information about Intellia Therapeutics Inc Headquarters? The links below have collected all the necessary data.

Home - Intellia Therapeutics

https://www.intelliatx.com/

Jun 26, 2021 · Overview. Intellia is a pioneer in the development of CRISPR/Cas9 genome editing and is rapidly moving experimental therapies towards the clinic. Our company’s unique strengths include our modular lipid nanoparticle delivery system and our determined focus on product development. Learn About Our Mission.

Contact - Intellia Therapeutics

https://www.intelliatx.com/contact/

Patients and Medical Affairs Contact. Clinical trial A test of a new medical treatment or procedure in human volunteers with the purpose of evaluating a medical, surgical or behavioral intervention. Clinical trials typically follow preclinical (non-human) studies and are the primary way that clinical researchers and regulatory agencies evaluate whether a new treatment is safe and effective in ...Estimated Reading Time: 50 secs

Intellia Therapeutics Opens New Headquarters as Company ...

https://ir.intelliatx.com/news-releases/news-release-details/intellia-therapeutics-opens-new-headquarters-company-continues

Dec 01, 2016 · Intellia Therapeutics is a leading genome editing company, focused on the development of proprietary, potentially curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course.

Intellia Therapeutics Corporate Headquarters, Office ...

https://craft.co/intellia-therapeutics-714/locations

All Intellia Therapeutics Locations. Cambridge (HQ), MA. United States. 40 Erie St #130. Report incorrect company information. Location of similar companies. Ionis Pharmaceuticals. Healthcare - Public. 4D Molecular Therapeutics.

Intellia Therapeutics Company Profile - Office Locations ...

https://craft.co/intellia-therapeutics-714

Jul 29, 2021 · Intellia Therapeutics has 270 employees at their 1 location and $57.99 M in annual revenue in FY 2020. See insights on Intellia Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.Employees: 270

Intellia Therapeutics Inc. - Company Profile - BCIQ

https://www.biocentury.com/companies/intellia_therapeutics_inc

Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more.

SEC

https://www.sec.gov/Archives/edgar/data/1652130/000156459018008288/0001564590-18-008288.txt

0001564590-18-008288.txt : 20180417 0001564590-18-008288.hdr.sgml : 20180417 0001564590-18-008288.hdr.sgml : 20180417

3 Biotech Stocks Up on Intellia's CRISPR Therapy Study Data

https://sg.finance.yahoo.com/news/3-biotech-stocks-intellias-crispr-135501337.html

Jun 29, 2021 · The gene-editing field crossed a major milestone as Intellia Therapeutics NTLA announced data from the first-ever human study evaluating an in vivo CRISPR-based gene editing therapy candidate. Last weekend, Intellia and its partner, Regeneron REGN announced interim data from a phase I study evaluating their in vivo CRISPR genome editing candidate, NTLA-2001, that supported potential of this ...

Individual Company Research Reports - Equity Research ...

https://www.raymondjames.com/wealth-management/advice-products-and-services/investment-solutions/research-areas/equity-research/individual-company-research-reports

In fact, Raymond James & Associates publishes research on approximately 200 large companies with more than $5 billion in market capitalization, but more than 70% of our coverage universe falls between $100 million and $5 billion in market capitalization. For more information about obtaining our research reports, please contact your financial ...

Willetton Uniforms